These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 27095827
1. Perk Ablation Ameliorates Myelination in S63del-Charcot-Marie-Tooth 1B Neuropathy. Musner N, Sidoli M, Zambroni D, Del Carro U, Ungaro D, D'Antonio M, Feltri ML, Wrabetz L. ASN Neuro; 2016; 8(2):. PubMed ID: 27095827 [Abstract] [Full Text] [Related]
2. Ablation of Perk in Schwann Cells Improves Myelination in the S63del Charcot-Marie-Tooth 1B Mouse. Sidoli M, Musner N, Silvestri N, Ungaro D, D'Antonio M, Cavener DR, Feltri ML, Wrabetz L. J Neurosci; 2016 Nov 02; 36(44):11350-11361. PubMed ID: 27807175 [Abstract] [Full Text] [Related]
3. Phosphorylation of eIF2α Promotes Schwann Cell Differentiation and Myelination in CMT1B Mice with Activated UPR. Scapin C, Ferri C, Pettinato E, Bianchi F, Del Carro U, Feltri ML, Kaufman RJ, Wrabetz L, D'Antonio M. J Neurosci; 2020 Oct 14; 40(42):8174-8187. PubMed ID: 32973043 [Abstract] [Full Text] [Related]
4. Calcineurin Activity Is Increased in Charcot-Marie-Tooth 1B Demyelinating Neuropathy. Sidoli M, Reed CB, Scapin C, Paez P, Cavener DR, Kaufman RJ, D'Antonio M, Feltri ML, Wrabetz L. J Neurosci; 2021 May 19; 41(20):4536-4548. PubMed ID: 33879538 [Abstract] [Full Text] [Related]
5. Resetting translational homeostasis restores myelination in Charcot-Marie-Tooth disease type 1B mice. D'Antonio M, Musner N, Scapin C, Ungaro D, Del Carro U, Ron D, Feltri ML, Wrabetz L. J Exp Med; 2013 Apr 08; 210(4):821-38. PubMed ID: 23547100 [Abstract] [Full Text] [Related]
6. Schwann cells ER-associated degradation contributes to myelin maintenance in adult nerves and limits demyelination in CMT1B mice. Volpi VG, Ferri C, Fregno I, Del Carro U, Bianchi F, Scapin C, Pettinato E, Solda T, Feltri ML, Molinari M, Wrabetz L, D'Antonio M. PLoS Genet; 2019 Apr 08; 15(4):e1008069. PubMed ID: 30995221 [Abstract] [Full Text] [Related]
7. Ablation of the UPR-mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B mice. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, Quattrini A, Feltri ML, Wrabetz L. Neuron; 2008 Feb 07; 57(3):393-405. PubMed ID: 18255032 [Abstract] [Full Text] [Related]
8. Sustained Expression of Negative Regulators of Myelination Protects Schwann Cells from Dysmyelination in a Charcot-Marie-Tooth 1B Mouse Model. Florio F, Ferri C, Scapin C, Feltri ML, Wrabetz L, D'Antonio M. J Neurosci; 2018 May 02; 38(18):4275-4287. PubMed ID: 29610440 [Abstract] [Full Text] [Related]
9. MpzR98C arrests Schwann cell development in a mouse model of early-onset Charcot-Marie-Tooth disease type 1B. Saporta MA, Shy BR, Patzko A, Bai Y, Pennuto M, Ferri C, Tinelli E, Saveri P, Kirschner D, Crowther M, Southwood C, Wu X, Gow A, Feltri ML, Wrabetz L, Shy ME. Brain; 2012 Jul 02; 135(Pt 7):2032-47. PubMed ID: 22689911 [Abstract] [Full Text] [Related]
10. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Patzkó A, Bai Y, Saporta MA, Katona I, Wu X, Vizzuso D, Feltri ML, Wang S, Dillon LM, Kamholz J, Kirschner D, Sarkar FH, Wrabetz L, Shy ME. Brain; 2012 Dec 02; 135(Pt 12):3551-66. PubMed ID: 23250879 [Abstract] [Full Text] [Related]
11. Activation of XBP1s attenuates disease severity in models of proteotoxic Charcot-Marie-Tooth type 1B. Touvier T, Veneri FA, Claessens A, Ferri C, Mastrangelo R, Sorgiati N, Bianchi F, Valenzano S, Del Carro U, Rivellini C, Duong P, Shy ME, Kelly JW, Svaren J, Wiseman RL, D'Antonio M. bioRxiv; 2024 Feb 02. PubMed ID: 38352425 [Abstract] [Full Text] [Related]
12. Pathology of a mouse mutation in peripheral myelin protein P0 is characteristic of a severe and early onset form of human Charcot-Marie-Tooth type 1B disorder. Rünker AE, Kobsar I, Fink T, Loers G, Tilling T, Putthoff P, Wessig C, Martini R, Schachner M. J Cell Biol; 2004 May 24; 165(4):565-73. PubMed ID: 15148307 [Abstract] [Full Text] [Related]
13. Targeting the colony stimulating factor 1 receptor alleviates two forms of Charcot-Marie-Tooth disease in mice. Klein D, Patzkó Á, Schreiber D, van Hauwermeiren A, Baier M, Groh J, West BL, Martini R. Brain; 2015 Nov 24; 138(Pt 11):3193-205. PubMed ID: 26297559 [Abstract] [Full Text] [Related]
14. Raising cGMP restores proteasome function and myelination in mice with a proteotoxic neuropathy. VerPlank JJS, Gawron J, Silvestri NJ, Feltri ML, Wrabetz L, Goldberg AL. Brain; 2022 Mar 29; 145(1):168-178. PubMed ID: 34382059 [Abstract] [Full Text] [Related]
15. Treatment with IFB-088 Improves Neuropathy in CMT1A and CMT1B Mice. Bai Y, Treins C, Volpi VG, Scapin C, Ferri C, Mastrangelo R, Touvier T, Florio F, Bianchi F, Del Carro U, Baas FF, Wang D, Miniou P, Guedat P, Shy ME, D'Antonio M. Mol Neurobiol; 2022 Jul 29; 59(7):4159-4178. PubMed ID: 35501630 [Abstract] [Full Text] [Related]
16. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells. Barbaria EM, Kohl B, Buhren BA, Hasenpusch-Theil K, Kruse F, Küry P, Martini R, Müller HW. Neurobiol Dis; 2009 Mar 29; 33(3):448-58. PubMed ID: 19111616 [Abstract] [Full Text] [Related]
17. Myelin abnormality in Charcot-Marie-Tooth type 4J recapitulates features of acquired demyelination. Hu B, McCollum M, Ravi V, Arpag S, Moiseev D, Castoro R, Mobley B, Burnette B, Siskind C, Day J, Yawn R, Feely S, Li Y, Yan Q, Shy M, Li J. Ann Neurol; 2018 Apr 29; 83(4):756-770. PubMed ID: 29518270 [Abstract] [Full Text] [Related]
18. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Horn M, Baumann R, Pereira JA, Sidiropoulos PN, Somandin C, Welzl H, Stendel C, Lühmann T, Wessig C, Toyka KV, Relvas JB, Senderek J, Suter U. Brain; 2012 Dec 29; 135(Pt 12):3567-83. PubMed ID: 23171661 [Abstract] [Full Text] [Related]